Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Pashayan

Showing results (111-120 of 180) with videos related to

Pageof 18
Sort By:
Genome Medicine|June 14, 2022
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy womenThomas E Bartlett, Iona Evans, Allison Jones, et al.
NPJ Breast Cancer|June 25, 2026
Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriersMartin Widschwendter, Rita Schmutzler, Nora Pashayan, et al.
Journal of Personalized Medicine|August 27, 2021
Risk-Stratified Approach to Breast Cancer Screening in Canada: Women's Knowledge of the Legislative Context and Concerns about Discrimination from Genetic and Other Predictive Health DataSamuel Alarie, Julie Hagan, Gratien Dalpé, et al.
European Journal of Epidemiology|July 18, 2021
Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL consortiumCharlotte Salmon, Lixin Song, Kenneth Muir, et al.
JAMA|April 6, 2024
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical TrialRichard M Martin, Emma L Turner, Grace J Young, et al.
Cancers|May 13, 2026
Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation ProjectXin Yang, Juliet A Usher-Smith, Kristina M Blackmore, et al.
Nature Genetics|June 13, 2017
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumorKevin Litchfield, Max Levy, Giulia Orlando, et al.
Blood|September 9, 2018
Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphomaAmit Sud, Hauke Thomsen, Giulia Orlando, et al.
Journal of Personalized Medicine|July 2, 2021
Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)Jennifer D Brooks, Hermann H Nabi, Irene L Andrulis, et al.
Communications Medicine|April 21, 2026
Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in CanadaNareh Safieh-Garabedian, Antonis C Antoniou, Jennifer Brooks, et al.
Pageof 18

Showing results (111-120 of 180) with videos related to

Sort By:
Pageof 18
Genome Medicine|June 14, 2022
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy womenThomas E Bartlett, Iona Evans, Allison Jones, et al.
NPJ Breast Cancer|June 25, 2026
Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriersMartin Widschwendter, Rita Schmutzler, Nora Pashayan, et al.
Journal of Personalized Medicine|August 27, 2021
Risk-Stratified Approach to Breast Cancer Screening in Canada: Women's Knowledge of the Legislative Context and Concerns about Discrimination from Genetic and Other Predictive Health DataSamuel Alarie, Julie Hagan, Gratien Dalpé, et al.
European Journal of Epidemiology|July 18, 2021
Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL consortiumCharlotte Salmon, Lixin Song, Kenneth Muir, et al.
JAMA|April 6, 2024
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical TrialRichard M Martin, Emma L Turner, Grace J Young, et al.
Cancers|May 13, 2026
Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation ProjectXin Yang, Juliet A Usher-Smith, Kristina M Blackmore, et al.
Nature Genetics|June 13, 2017
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumorKevin Litchfield, Max Levy, Giulia Orlando, et al.
Blood|September 9, 2018
Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphomaAmit Sud, Hauke Thomsen, Giulia Orlando, et al.
Journal of Personalized Medicine|July 2, 2021
Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)Jennifer D Brooks, Hermann H Nabi, Irene L Andrulis, et al.
Communications Medicine|April 21, 2026
Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in CanadaNareh Safieh-Garabedian, Antonis C Antoniou, Jennifer Brooks, et al.
Pageof 18